Effects Of Alpha-lipoic Acid Supplementation In Peripheral Arterial Disease: A Pilot Study
| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 28 |
| Sex | Both Genders |
| Age Range | 65+ |
| Body Types | Overweight, Average |
3 months of ALA supplementation in a population of peripheral arterial disease with 600mg ALA daily.
Reduction of subjective pain and a beneficial trend of blood health and claudation were noted. Oxidative stress did not differ between groups, nor did C-reactive protein.
